- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2012-004060-22. Displaying page 1 of 1.
|EudraCT Number: 2012-004060-22||Sponsor Protocol Number: 107824/107826/107829||Start Date*: 2015-06-01|
|Sponsor Name:GlaxoSmithKline Biologicals|
|Full Title: A phase II, open, controlled, multicenter study to evaluate the long-term antibody persistence at 1, 3 and 5 years after the administration of a four dose vaccination series of Hib-MenCY-TT vaccine...|
|Medical condition: Invasive disease caused by Haemophilus type b and Neisseria meningitidis serogroups C and Y|
|Population Age: Children, Under 18||Gender: Male, Female|
|Trial protocol: Outside EU/EEA|
|Trial results: View results|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.